Hosted on MSN2d
FDA Expands Approval of Esketamine for Depression
The FDA approved esketamine (Spravato) nasal spray as monotherapy for adults with treatment-resistant depression who had an ...
The American Journal of Managed Care2d
Esketamine Approved by FDA as First Monotherapy for Treatment-Resistent Depression
Esketamine (Spravato; Johnson & Johnson) is now the first and only monotherapy for adults with major depressive disorder (MDD ...
KJZZ2d
FDA allows standalone use of nasal spray antidepressant Spravato (esketamine)
The FDA says esketamine, an antidepressant derived from the anesthetic and party drug ketamine, can now be prescribed on its ...
What is Spravato, an FDA-approved First Standalone Esketamine-based Nasal Spray Monotherapy for Depression?
The US Food and Drug Administration has approved a new nasal spray for depression treatment. Known as Spravato and ...
pharmaphorum3d
FDA approves Janssen’s ketamine-based nasal antidepressant
Spravato (esketamine) has been touted as a potential blockbuster for Janssen, which faces increasing biosimilar competition from its top-selling rheumatoid arthritis drug Remicade. Estimates from ...
Medscape3d
Biological Aspects of Postpartum Depression
In comparison with the vast epidemiological literature on postpartum depression (PPD), relatively few studies have examined the biological aspects of the disorder. However, research into the ...
WFSU6d
Ohio's Lt. Gov. Jon Husted to fill U.S. Senate seat vacated by JD Vance
Ohio's Lt. Gov. Jon Husted will be the state's next U.S. Senator. Gov. Mike DeWine announced his pick to replace Vice-President elect JD Vance in the Senate on Friday. Vance resigned from the chamber ...